WallStreetZenWallStreetZen

NASDAQ: CMND
Clearmind Medicine Inc Stock

$1.17+0.03 (+2.63%)
Updated Mar 27, 2024
CMND Price
$1.17
Fair Value Price
N/A
Market Cap
$3.71M
52 Week Low
$0.92
52 Week High
$50.10
P/E
-0.04x
P/B
0.74x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.09M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1
Operating Cash Flow
-$4M
Beta
-0.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CMND Overview

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CMND scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CMND is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMND is good value based on its book value relative to its share price (0.74x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
CMND is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CMND due diligence checks available for Premium users.

Be the first to know about important CMND news, forecast changes, insider trades & much more!

CMND News

Valuation

CMND fair value

Fair Value of CMND stock based on Discounted Cash Flow (DCF)
Price
$1.17
Fair Value
$0.07
Overvalued by
1,558.73%
CMND is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CMND price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.04x
Industry
14.3x
Market
44.45x

CMND price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.74x
Industry
6.2x
CMND is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CMND's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.4M
Profit Margin
0%
CMND's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$10.1M
Liabilities
$5.1M
Debt to equity
1
CMND's short-term assets ($9.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CMND's short-term assets ($9.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CMND's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
$0.0
Financing
$5.3M
CMND's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CMND vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CMND$3.71M+2.63%-0.04x0.74x
JAGX$3.71M+5.80%-0.03x2.72x
AVTX$3.81M+2.72%-0.01x0.26x
OGEN$3.60M-0.71%-0.29x0.55x
SNPX$3.89M-3.54%-0.18x0.15x

Clearmind Medicine Stock FAQ

What is Clearmind Medicine's quote symbol?

(NASDAQ: CMND) Clearmind Medicine trades on the NASDAQ under the ticker symbol CMND. Clearmind Medicine stock quotes can also be displayed as NASDAQ: CMND.

If you're new to stock investing, here's how to buy Clearmind Medicine stock.

What is the 52 week high and low for Clearmind Medicine (NASDAQ: CMND)?

(NASDAQ: CMND) Clearmind Medicine's 52-week high was $50.10, and its 52-week low was $0.92. It is currently -97.66% from its 52-week high and 27.17% from its 52-week low.

How much is Clearmind Medicine stock worth today?

(NASDAQ: CMND) Clearmind Medicine currently has 3,169,570 outstanding shares. With Clearmind Medicine stock trading at $1.17 per share, the total value of Clearmind Medicine stock (market capitalization) is $3.71M.

Clearmind Medicine stock was originally listed at a price of $177.00 in Nov 15, 2022. If you had invested in Clearmind Medicine stock at $177.00, your return over the last 1 years would have been -99.34%, for an annualized return of -99.34% (not including any dividends or dividend reinvestments).

How much is Clearmind Medicine's stock price per share?

(NASDAQ: CMND) Clearmind Medicine stock price per share is $1.17 today (as of Mar 27, 2024).

What is Clearmind Medicine's Market Cap?

(NASDAQ: CMND) Clearmind Medicine's market cap is $3.71M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clearmind Medicine's market cap is calculated by multiplying CMND's current stock price of $1.17 by CMND's total outstanding shares of 3,169,570.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.